TBD Therapeutics Inc. develops breakthrough solution for the treatment of NEUROPATHIC PAIN
Meet the Team
Strategic selection of a "Power-House" with the knowledge & skill
CO-FOUNDERS
Esther Farkash
School of Pharmacy graduate with 25+ years experience in drug development & licensing processes at global leading pharmaceutical companies.
Tel-Aviv, Israel
Merav Krasner
BSc in life Science, with 25+ years of product development and commercial experience in the global pharmaceutical, diagnostics and medical devices industries.
New Jersey, USA
Meet the Team
Strategic selection of a "Power-House" with the knowledge & skill
Until February 2023, Our Scientific Advisor was
The Designer of the Proprietary Molecule- Prof. Mechoulam.
Sadly, he passed away March 2023
.jpg)
Prof. Raphael Mechoulam
The School of Pharmacy,
The Hebrew University, Jerusalem, Israel
Prof. Mechoulam's discovery of the chemical structure of the main compounds of the Cannabis plant as well as the Endo-Cannabinoid System in the body, triggered the extensive worldwide research and usage of natural and synthetic novel compounds.
Some of which have been approved for use by the FDA.
From April 2023 , our Scientific Advisor is
Prof. Doron Steinberg
The Hebrew University, Jerusalem, Israel
Prof. Doron Steinberg is The Head of the BIOFILM Research Laboratory and a researcher at The Multidisciplinary Center for Cannabinoids research at The Hebrew University in Jerusalem, Israel.
Prof. Steinberg worked with the molecule designer Prof. Mechoulam on different research projects concerning Cannabinoids.
They have registered a patent following their mutual work.
Prof. Steinberg has many patents of which one has evolved into a commercial product- PerioChip, a prescription medicine.
Meet the Team
Strategic selection of a "Power-House" with the knowledge & skill
Consultants & Service Providers
included in the Investor Deck